External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Mastek is positioning itself for its next phase of growth with a clear focus on its regional strength, particularly in the UK government (SGS and NHS), while simultaneously rebuilding its US and AMEA businesses</li><li>The company maintains a highly optimistic outlook for the UK-Europe region (~64% of revenue), targeting mid-teen growth, driven by strong momentum in digital healthcare initiatives, supported by the UK government’s ~£10bn commitment (~£2bn digital spends)</li><li>Healthcare has emerged as Mastek’s fastest-growing segment, further strengthened by its strong track record with the UK government contracts</li><li>Additionally, Mastek is aggressively pursuing new opportunities in Secured Government Services (SGS) and expanding presence in departments such as the Home Office, HMRC, and Ministry of Defence.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Mastek is positioning itself for its next phase of growth with a clear focus on its regional strength, particularly in the UK government (SGS and NHS), while simultaneously rebuilding its US and AMEA businessesThe company maintains a highly optimistic outlook for the UK-Europe region (~64% of revenue), targeting mid-teen growth, driven by strong momentum in digital healthcare initiatives, supported by the UK government’s ~£10bn commitment (~£2bn digital spends)Healthcare has emerged as Mastek’s fastest-growing segment, further strengthened by its strong track record with the UK government contractsAdditionally, Mastek is aggressively pursuing new opportunities in Secured Government Services (SGS) and expanding presence in departments such as the Home Office, HMRC, and Ministry of Defence.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mastek Ltd

Mastek: UK to Drive Growth. Maintain BUY